RITUXIMAB IN COMBINATION WITH BENDAMUSTINE OR HIGH‐DOSE CYTARABINE‐BASED INDUCTION THERAPY IN TRANSPLANT‐ELIGIBLE PATIENTS WITH MANTLE CELL LYMPHOMA

Autor:	Olivier Hermine, Kerry J. Savage, Eva Hoster, Michal Szymczyk, Ciara L. Freeman, A. Bosly, M. Unterhalt, David Scott, W. Klapper, Alina S. Gerrie, M. Dreyling, Laurie H. Sehn, Diego Villa
Rok vydání:	2021
Předmět:	Oncology Bendamustine Cancer Research medicine.medical_specialty business.industry Hematology General Medicine medicine.disease High dose cytarabine Induction therapy Internal medicine medicine Rituximab Mantle cell lymphoma business medicine.drug
Zdroj:	Hematological Oncology. 39
ISSN:	1099-1069 0278-0232
DOI:	10.1002/hon.62_2880
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c6503a186bb6acb6d7bc0315051a09e9 https://doi.org/10.1002/hon.62_2880 Zobrazit plný text záznamu Plný text